1. Home
  2. PYXS vs CURR Comparison

PYXS vs CURR Comparison

Compare PYXS & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYXS
  • CURR
  • Stock Information
  • Founded
  • PYXS 2018
  • CURR 2013
  • Country
  • PYXS United States
  • CURR Singapore
  • Employees
  • PYXS N/A
  • CURR N/A
  • Industry
  • PYXS Biotechnology: Pharmaceutical Preparations
  • CURR Business Services
  • Sector
  • PYXS Health Care
  • CURR Consumer Discretionary
  • Exchange
  • PYXS Nasdaq
  • CURR Nasdaq
  • Market Cap
  • PYXS 66.3M
  • CURR 74.0M
  • IPO Year
  • PYXS 2021
  • CURR N/A
  • Fundamental
  • Price
  • PYXS $1.17
  • CURR $0.43
  • Analyst Decision
  • PYXS Strong Buy
  • CURR Strong Buy
  • Analyst Count
  • PYXS 5
  • CURR 1
  • Target Price
  • PYXS $9.00
  • CURR $3.50
  • AVG Volume (30 Days)
  • PYXS 405.6K
  • CURR 2.5M
  • Earning Date
  • PYXS 08-13-2025
  • CURR 08-11-2025
  • Dividend Yield
  • PYXS N/A
  • CURR N/A
  • EPS Growth
  • PYXS N/A
  • CURR N/A
  • EPS
  • PYXS N/A
  • CURR N/A
  • Revenue
  • PYXS N/A
  • CURR $43,386,858.00
  • Revenue This Year
  • PYXS N/A
  • CURR N/A
  • Revenue Next Year
  • PYXS N/A
  • CURR $21.53
  • P/E Ratio
  • PYXS N/A
  • CURR N/A
  • Revenue Growth
  • PYXS N/A
  • CURR N/A
  • 52 Week Low
  • PYXS $0.83
  • CURR $0.33
  • 52 Week High
  • PYXS $5.39
  • CURR $7.08
  • Technical
  • Relative Strength Index (RSI)
  • PYXS 46.51
  • CURR N/A
  • Support Level
  • PYXS $1.14
  • CURR N/A
  • Resistance Level
  • PYXS $1.41
  • CURR N/A
  • Average True Range (ATR)
  • PYXS 0.08
  • CURR 0.00
  • MACD
  • PYXS -0.02
  • CURR 0.00
  • Stochastic Oscillator
  • PYXS 12.73
  • CURR 0.00

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants world-wide, delivering frictionless interoperable real-time fund transfers and instant messaging.

Share on Social Networks: